Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada

Transfusion ◽  
2018 ◽  
Vol 58 (9) ◽  
pp. 2243-2249 ◽  
Author(s):  
Christina L. Dean ◽  
Harold C. Sullivan ◽  
Sean R. Stowell ◽  
Ross M. Fasano ◽  
Lori J. West ◽  
...  
Keyword(s):  
United States ◽  
Heart Transplant ◽  
The United States ◽  
Transplant Patients ◽  
Current State ◽  
Pediatric Heart Transplant

Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change

2021 ◽  
Author(s):  
Ryan J. Williams ◽  
Minmin Lu ◽  
Lynn A. Sleeper ◽  
Elizabeth D. Blume ◽  
Paul Esteso ◽  
...  
Keyword(s):  
United States ◽  
Policy Change ◽  
Heart Transplant ◽  
Waiting Times ◽  
The United States ◽  
Allocation Policy ◽  
Pediatric Heart Transplant

485 Hospital Charges for Pediatric Heart Transplant Hospitalizations in the United States from 1997 to 2006

2011 ◽  
Vol 30 (4) ◽  
pp. S165
Author(s):  
J.W. Rossano ◽  
S. Law ◽  
J.A. Decker ◽  
J.F. Price ◽  
A.G. Cabrera ◽  
...  
Keyword(s):  
United States ◽  
Heart Transplant ◽  
The United States ◽  
Hospital Charges ◽  
Pediatric Heart Transplant

Hospital charges for pediatric heart transplant hospitalizations in the United States from 1997 to 2006

2012 ◽  
Vol 31 (5) ◽  
pp. 485-491 ◽  
Author(s):  
Sabrina P. Law ◽  
Jeffrey J. Kim ◽  
Jamie A. Decker ◽  
Jack F. Price ◽  
Antonio G. Cabrera ◽  
...  
Keyword(s):  
United States ◽  
Heart Transplant ◽  
The United States ◽  
Hospital Charges ◽  
Pediatric Heart Transplant

scholarly journals Ice-Breaking Fleets of the United States and Canada: Assessing the Current State of Affairs and Future Plans

2021 ◽  
Vol 13 (2) ◽  
pp. 703
Author(s):  
Megan Drewniak ◽  
Dimitrios Dalaklis ◽  
Anastasia Christodoulou ◽  
Rebecca Sheehan
Keyword(s):  
United States ◽  
The United States ◽  
Maritime Transportation ◽  
The Arctic ◽  
Polar Ice ◽  
Northwest Passage ◽  
Ice Cap ◽  
Ice Coverage ◽  
Current State ◽  
State Of Affairs

In recent years, a continuous decline of ice-coverage in the Arctic has been recorded, but these high latitudes are still dominated by earth’s polar ice cap. Therefore, safe and sustainable shipping operations in this still frozen region have as a precondition the availability of ice-breaking support. The analysis in hand provides an assessment of the United States’ and Canada’s polar ice-breaking program with the purpose of examining to what extent these countries’ relevant resources are able to meet the facilitated growth of industrial interests in the High North. This assessment will specifically focus on the maritime transportation sector along the Northwest Passage and consists of four main sections. The first provides a very brief description of the main Arctic passages. The second section specifically explores the current situation of the Northwest Passage, including the relevant navigational challenges, lack of infrastructure, available routes that may be used for transit, potential choke points, and current state of vessel activity along these routes. The third one examines the economic viability of the Northwest Passage compared to that of the Panama Canal; the fourth and final section is investigating the current and future capabilities of the United States’ and Canada’s ice-breaking fleet. Unfortunately, both countries were found to be lacking the necessary assets with ice-breaking capabilities and will need to accelerate their efforts in order to effectively respond to the growing needs of the Arctic. The total number of available ice-breaking assets is impacting negatively the level of support by the marine transportation system of both the United States and Canada; these two countries are facing the possibility to be unable to effectively meet the expected future needs because of the lengthy acquisition and production process required for new ice-breaking fleets.

Biosurveillance: A Modern Look

2020 ◽  
Vol 11 (1) ◽  
Author(s):  
James Lee Brooks
Keyword(s):  
United States ◽  
Homeland Security ◽  
The United States ◽  
First Century ◽  
Direct Result ◽  
Current State ◽  
Twenty First Century ◽  
Security Operations

AbstractThe early part of the twenty-first century saw a revolution in the field of Homeland Security. The 9/11 attacks, shortly followed thereafter by the Anthrax Attacks, served as a wakeup call to the United States and showed the inadequacy of the current state of the nation’s Homeland Security operations. Biodefense, and as a direct result Biosurveillance, changed dramatically after these tragedies, planting the seeds of fear in the minds of Americans. They were shown that not only could the United States be attacked at any time, but the weapon could be an invisible disease-causing agent.

scholarly journals The United States’ Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research

2019 ◽  
Vol 24 (3) ◽  
pp. 147-152 ◽  
Author(s):  
Daniel Eisenman
Keyword(s):  
United States ◽  
Gene Therapy ◽  
Clinical Trials ◽  
The United States ◽  
Regulatory Environment ◽  
Evidence Based ◽  
Regulatory Structure ◽  
Regulatory Changes ◽  
Current State ◽  
Therapy Field

Introduction: A dramatic increase in the number of clinical trials involving gene-modified cell therapy and gene therapy is taking place. The field is on the verge of a boom, and the regulatory environment is evolving to accommodate the growth. Discussion: This commentary summarizes the current state of the field, including an overview of the growth. The United States (US) regulatory structure for gene therapy will be summarized, and the evolution of the oversight structure will be explained. Conclusion: The gene therapy field has recently produced its first FDA-approved therapeutics and has a pipeline of other investigational products in the final stages of clinical trials before they can be evaluated by the FDA as safe and effective therapeutics. As research continues to evolve, so must the oversight structure. Biosafety professionals and IBCs have always played key roles in contributing to the safe, evidence-based advancement of gene therapy research. With the recent regulatory changes and current surge in gene therapy research, the importance of those roles has increased dramatically.

Sign in / Sign up

Export Citation Format

Share Document